Kaituo Pharmaceutical-B (09939.HK) announced on August 9 that the board of directors meeting will be held on August 26, 2024 (Monday) to consider and approve the mid-term performance of the company and its subsidiaries ending on June 30, 2024, including its release.
开拓药业-B(09939.HK)8月26日举行董事会会考虑及批准中期业绩
Kaituo Pharmaceutical-B (09939.HK) held a board of directors meeting on August 26 to consider and approve its interim performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated